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Abstract: Secondary metabolites continue to offer a promising source of
novel chemical entities with therapeutic bioactivities. Our research aims to
isolate secondary metabolites produced by non-ribosomal peptide
synthetase (NRPS) and polyketide synthase (PKS) constructs. A
metagenomic library was created from the marine bacterium
Pseudoalteromonas sp., which was isolated from the Chesapeake Bay
sponge Halichondria bowerbanki. Using a functional screen for PPTase
activity we were able to identify colonies that contained NRPS and PKS
gene clusters. Cultures of this microbe have been produced and analyzed
using a combination of chromatography and 1H, 13C, HMBC, HSQC,
COSY, AND NOESY NMR spectra. We were able to isolate a potential
partial product from one of these gene clusters. Further investigation will
be needed to confirm the identity of this compound, and perform biological
assays to screen for relevant therapeutic activity.

INTRODUCTION
Natural products have been used for medicinal purposes since 2600 B.C., when the
ancient Mesopotamians documented the use of Cypress oils for the treatment of coughs,
colds, and inflammation.1 A proverbial ‘Golden Age of Antibiotics’ occurred beginning
with the discovery of Penicillin in 1929 and continuing into the 1960s. During this time
more than one half of the antibiotics used in the healthcare industry today were
discovered.2 This remarkable period of discovery began to dwindle as researchers
encountered considerable difficulties due to replication (the isolation of the same
compounds over and over). In an effort to combat replication and push natural product
discovery, major pharmaceutical companies developed natural product discovery
programs, which screened for bioactive compounds that could be developed into
marketable pharmaceuticals.3 Many pharmaceutical companies, however, ended their
natural product discovery programs in the 1990s and early 2000s as the rise of high
throughput screening led to a preference towards combinatorial chemistry for future drug

1

Cragg, G.M.; Newman, D.J. Biodiversity: A Continuing Source of Novel Drug Leads. Pure Appl. Chem.
2005; 77: 7-24
2 Davies, J. Where have all the antibiotics gone? Can J Infect Dis Med Microbiol. 2006; 17(5):287-290.
3
Baker, D.D.; Chu, M.; Oza, U.; Rajgarhia, V. The value of natural products to future pharmaceutical
discovery. Nat Prod Rep. 2007; 24(6):1225-44.
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research.4 Although natural product research by many pharmaceutical companies has
declined in the last several decades, of the 1,184 new chemical entities studied from the
period 1981-2006, 52% were natural products or derived from natural products, with only
32% being purely synthetic molecules.

Therefore, natural product isolation and characterization may still promise novel
compounds with bioactive and therapeutic properties. These molecules are defined as
secondary metabolites and differ from primary metabolites in that they are not a part of
primary metabolism (i.e. the breakdown of proteins, fats, nucleic acids, and
carbohydrates needed for survival).5 Rather, natural products are essential to providing an
organism with some sort of selective advantage in its natural environment and therefore
often have important properties such as antibiotic, antitumor, or anti-inflammatory
activity.6 Indeed, some of the most famous drug discoveries of the last century have come
from a variety of secondary
metabolites such as: the
antibiotics penicillin and
vancomycin from the fungi
Penicillium notatum and
Amycolatopsis orientalis
respectively; paclitaxel
(Taxol®) from the bark of
Taxus brevifolia; and the
Figure 1. Notable secondary metabolites isolated and
manufactured for pharmaceutical purposes. a) vancomycin b)
paclitaxel c) penicillin d) prostratin.

antiviral compound prostratin
from Homalanthus natuans,
which has shown promise in

4

Nussbaum, F.V.; Brands, M.; Hinzen, B.; Weigand, S.; Habich, D. Antibacterial natural products in
medicinal chemistry – exodus or revival? Angew. Chem Int. Ed. 2006; 45: 5072-5129
5
Dweick, P.M. A Historical Overview of Natural Products in Drug Discovery. Medicinal Natural
Products: A Biosynthentic Approach, 2nd ed.; John Wiley and Son: West Sussex, UK, 2002; p. 520
6
Maplestone, R.A.; Stone, M.J.; Williams D.H. The evolutionary role of secondary metabolites—A
review. Gene 1992, 115, 151-157
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combatting HIV.7 The structures in Figure 1 demonstrate the highly conjugated, aromatic,
and stereochemically diverse nature of many natural products on the market today.

Approximately 99% of all microbes are not able to be cultured given their complex
requirements for growth, which include specific pH, temperature, and nutrient
conditions.8 This makes them a generally underutilized source for isolating chemical
entities. Of particular interest are microbes with non-ribosomal peptide synthetase
(NRPS) and polyketide synthase (PKS) gene clusters. These large multifunctional
enzyme systems are used to synthesize complex secondary metabolites using simple
building blocks such as carboxylic acids and amino acids.9 These enzyme complexes
consist of multiple domains constructed in an assembly line-like fashion, where a
substrate is shuttled from one domain to the next during synthesis and modification.

This multimodular
construction makes
possible the
synthesis of highly
complex and
stereochemically
diverse molecules.
Each module
contains a catalytic
domain with one of
several specified

7

Figure 2. The predicted NRPS gene cluster responsible for the
production of the newly discovered antibiotic teixobactin. a) the two
genes, txo1 and txo2, their associated enzymatic domains, and the amino
acids incorporated by each. b) schematic structure of the teixobactin
molecule. c) structure of teixobactin.

Dias, D.A.; Urban, S.; Roessner, U. A Historical Overview of Natural Products in Drug Discovery.
Metabolites 2012, 2, 303-336; doi: 10.3390/metabo2020303
8
Lewis, K. Platforms for antibiotic discovery. Nature Rev. Drug Discov. 2013; 12(5):371-87. doi:
10.1038/nrd3975.
9
Wenzel, S.C.; Muller, R. Formation of novel secondary metabolites by bacterial multimodular assembly
lines: deviations from textbook biosynthetic logic. Current Opinion in Chemical Biology 2005, 9:447
458
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functions. Figure 210 shows the NRPS construct responsible for the synthesis of the
antibiotic teixobactin. In section ‘a’, one can observe the individual domains responsible
for the chemical modifications required to produce the chemical entity of interest. These
domains include: adenylation, methylation, thiolation, condensation, and thioesterase
sites. The order of these domains and the identity of the substrate determine what the
final product will be. Due to their highly complex and diverse nature, our research aims
to isolate NRPS and PKS gene clusters from environmental samples using metagenomic
library construction in conjunction with a novel screening technique.

In order to identify NRPS and PKS gene
clusters we employed a novel functional
screen of 4’-Phosphopantetheinyl transferase
(PPTase) proteins. This class of enzymes is
responsible for the conversion of 4Phosphopantetheine (Ppant) carrier
proteins from an inactive to an active

Figure 3. The condensation of 2 L-Glutamine
molecules to the blue pigment indigoidine.
Colonies producing indigoidine are positive for
PPTase activity.

state, 11,12 allowing them to covalently
bond substrate intermediates such as reactive acyl thioesters, and shuttle them from one
reactive subunit to the next in a multidomain enzymatic system.13 Ppant carrier proteins
are often vital components of NRPS-and PKS-associated synthesis complexes and are
responsible for transferring the substrate of interest from one domain to the next, in a
fashion much akin to an assembly line. For this to be possible, PPTases must also be
actively transcribed and translated from their respective genes in NRPS and PKS gene
clusters for these Ppant carrier proteins to be active. For these reasons we chose PPTase
as the target molecule in our functional screen.

Losee, L.L. A new antibiotic kills pathogens without detectable resistance. Nature 2015; 517, 455–
459
11
Lambalot, R.H. et al. A new enzyme superfamily – the phosphopantetheinyl transferases. Chem. Biol. 3,
1996; 923-936
12
Lambalot, R.H. and Walsh, C.T. Cloning, overproduction and characterization of the Escherichia coli
Holo-acyl carrier protein synthase. J. Biol. Chem. 1995; 270, 24658-24661
13
Walsh, C.T., Gehring, A.M., Weinreb, P.H., Quadri, L.E. and Flugel, R.S. Post-translational modification
of polyketide and nonribosomal peptide synthases. Curr. Opin. Chem. Biol. 1997; 1, 309-315
10
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Our functional screen employs the Escherichia coli cell line EcoBlue 1. EcoBlue 1
contains a reporter plasmid with a small NRPS taken from Streptomyces lavendulae. This
NRPS is known as BpsA, and is able to condense two L-glutamine residues into a single
blue pigment: indigoidine (Figure 3).14 If a fosmid with a DNA insert containing a
PPTase gene is transformed into an ecoBlue 1 cell, BpsA will be activated, resulting in
the production of indigoidine and an easily identifiable blue colony (Figure 4).

Figure 4. The BpsA reporter plasmid responsible for indigoidine production in ecoBlue 1 cells.
Environmental DNA is sheered an inserted into a fosmid. The fosmid is transformed into the ecoBlue
cell line. If a PPTase exists on a particular insert, BpsA will be activated and produce
indigoidine, resulting in a blue colony.

Previous work in the Dattelbaum lab has generated two metagenomic fosmid libraries.
One library was created from environmental DNA isolated from soil collected on the
University of Richmond campus. The second was created from a cultivable strain of the
marine bacterium Pseudoalteromonas sp., arbitrarily named SW202. SW202 was isolated
from the sponge Halichondria bowerbanki by Dr. Malcolm Hill of the University of
Richmond, and generously provided for use in our lab. Screening of the SW202 fosmid
library in our functional assay yielded five positive colonies: designated A, B, C, D, and
E (a positive result being indicated by the production of blue pigment).

This paper will detail the work done to isolate novel secondary metabolites from positive
colony A. The metabolites in question were isolated using an NMR-guided approach to

14

Owen, J.G., Copp, J.N, and Ackerley, D.F. Rapid and flexible biochemical assays for evaluating 4’phosphopantetheinyl transferase activity. Biochem J. 2011: 436: 709-717
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natural product mining in conjunction with various chromatography techniques, including
high-pressure liquid chromatography (HPLC). The results are promising, indicating that
SW202A does in fact contain an as yet undetermined gene cluster responsible for the
production of unique compounds not found in a control sample.

METHODS
ZYP-5052 auto-induction broth (2L) [10 g yeast extract, 20 g N-Z amines (combined in
1600 mL of ultrapure water and autoclaved), 13.16 g glutamine, 10 mL glycerol, 1.0 g Dglucose, 4 g lactose, 14.196 g sodium phosphate dibasic, 6.608 g ammonium sulfate
dibasic, and 13.608 g potassium phosphate monobasic (combined in 400 mL ultrapure
water and filter sterilized into the autoclaved solution described above)] was prepared to
grow a culture from ecoBlue 1 cells of positive colony A (henceforth referred to as
ecoSW202A) and non-transformed ecoBlue 1 cells. The two cultures were grown for six
days at 16 °C and 200 RPM.

The cultures were centrifuged at 6750 xg to pellet the cells. The supernatant was
collected and the cell pellets were stored at -20 °C for later use in methanol extractions.
The supernatant underwent a first round of chromatography on a 30 mL Diaion® HP-20
open column. The column was prepared using successive washes of three column
volumes of acetone, water, and methanol. The supernatant was then applied to the
column and the flow-through discarded. Bound molecules were eluted from the column
using washes of 25% and 100% acetone (three column volumes each). The eluted
fractions were collected in 250 mL round bottom flasks and stored at 4 °C overnight.

The 100% acetone fractions from the ecoSW202A and ecoBlue 1 cultures were dried
using rotary evaporation and transferred to 20 mL scintillation vials. NMR spectroscopy
on a Bruker 500 MHz was performed on the two samples in CD3OD.

Both 100% acetone fractions were then further separated on a 30 mL Diaion® HP-20
column into 50%, 75%, and 100% acetone fractions. 1H NMR spectroscopy was
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performed on the three fractions of each sample in conjunction with 2-D HMBC
experiments. The resulting spectra for the corresponding ecoBlue 1 and
ecoSW202A fractions were compared and unique peaks were identified to focus further
chromatography on fractions with fosmid-associated compounds. The 50% acetone
ecoSW202A fraction was believed to have novel peaks.

Figure 5. Protocol for isolating novel products from ecoSW202A cell cultures. a) 2 L cultures were
grown, and the supernatant collected. b) HP20 open columns were used to fractionate metabolites by
polarity. c) HPLC was used to further purify the existing fractions. d) NMR spectroscopy was used to
characterize each fraction, and target NRPS and PKS compounds.

The 50% acetone
ecoSW202A fraction was
subjected to further
purification using a C18
semi-prep column on an
Agilent 1100 series HPLC
system. The ecoSW202A
50% acetone fraction (224
mg) was dissolved in 10
mL of HPLC-grade
methanol. The resulting
solution was syringe-

Figure 6. Overall fractionation scheme for a 2L culture of
ecoSW202A. The red fractions indicate samples with unique proton
peaks when compared to a spectra from the ecoBlue 1 control
culture.

filtered to remove any insoluble debris. Injections (10 L) of the solution were added for
20 minute runs with a flow rate of 4.0 mL/min. Runs began with 100% methanol, with
consecutive runs increasing the water content by 10% until satisfactory separation was
observed. The most effective solvent solution was a 1:1 water:methanol mixture. More
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polar mixtures led to large changes in the column’s properties, likely due to the very
hydrophobic nature of the resin used.

Seven unique fractions were eluted for the ecoSW202A extract. The resulting fractions
were back-loaded on a 3 mL Diaion® HP20SS column to remove water from the samples
and reduce drying times. The column was prepared with successive 9 mL washes of
acetone, water, and methanol. The fractions were then applied to the HP20SS column
under vacuum, and the flow-through discarded. The bound product was eluted from the
column in 9 mL of 100% acetone. The seven fractions were then dried via rotary
evaporation.
Each fraction was further analyzed using 1H NMR spectroscopy. The resulting spectra
were compared to the original ecoBlue 1 control spectra to identify novel peaks.
Fractions were subsequently subjected to further NMR analysis using 13C, 2-D HMBC,
HSQC, COSY, and NOESY experiments.

RESULTS AND DISCUSSION
FRACTION
HP-20 OPEN COLUMN (1)
25% acetone
100 % acetone
HP-20 OPEN COLUMN (2)
50% acetone
75% acetone
100% acetone
TOTAL
HPLC C18 SEMI-PREP COLUMN
F1
F2
F3
F4
F5
F6
F7
TOTAL

MASS (mg)

RECOVERY (%)

N/A*
320.9
224.0
45.5
2.2
271.7

84.67

9.5
12.0
9.6
5.2
4.9
5.0
7.3
53.5

85.57

Table 1. Mass yields from chromatography. Open column HP-20 and C18 HPLC Semi-Prep
chromatography were employed to purify a culture of ecoSW202A. The 100% acetone fraction from
HP-20 open column (1) was fractionated on HP-20 open column (2). The 50% acetone fraction from
HP-20 open column (2) was fractionated using HPLC. *The initial 25% acetone fraction was not
processed, and thus no weight is available.
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The mass for each chromatography fraction was recorded after thorough drying. The
results are shown in Table 1. Initially, 320.9 mg were recovered from the first round of
HP-20 chromatography in the 100% acetone fraction. After a second round of HP-20
chromatography 271.7 mg, or 84.67% of the original material, was recovered.
Approximately 67.20 mg of the 224.0 mg 50% acetone fraction were subjected to HPLC
purification. Of that 53.5 mg, or 85.57%, was recovered.
The purification progression of the ecoSW202A sample was tracked via 1H NMR
spectroscopy. After each round of chromatography, NMR spectra were obtained for the
resulting fractions. Figure 7 illustrates the improvement seen in resolution as well as
sample purity after an initial round of HPLC.
a

b

c

Figure 7. Results of chromatography purification. a) ecoSW202A 100% acetone fraction [from HP20 open column (1)]. b) ecoSW202A 50% acetone fraction [from HP-20 open column (2)]. c)
ecoSW202A F4 (from HPLC C18 Semi-Prep column).

When we transitioned to HPLC it was important to determine which experimental
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conditions would yield the best separation of our sample. To do this small injection
volumes were run with varying solvent mixtures to determine the most favorable. As
discussed above, a 1:1 methanol:water mixture provided the greatest separation without
altering the properties of the resin. Unfortunately, much of the resolution that was
obtained using the 10 L HPLC injections was lost when scaling up to 100 L injections
(Figure 8a-b). By observing peak intensity and separation at A254, we were able to
identify seven chromatography fractions. Fractions 1-7 were collected at 1.7, 2.7, 4.0,
4.7, 5.5, and 9.0 min, respectively (Figure 8b), and characterized via 1H NMR.

Figure 8. Using HPLC and 1H NMR spectroscopy to identify novel proton peaks. a) UV-Vis
readings at 254 nm for original 10 L injection of sample on C18 Semi-Prep column. b) UV-Vis
readings for 100 L sample injection on C18 Semi-Prep column. Dotted lines indicate the switch to a
new fraction. c) Top (red): 1H NMR from HPLC faction 4; bottom (blue): 1H NMR from ecoBlue 1
control. d) Top (red): 1H NMR from HPLC faction 6; bottom (blue): 1H NMR from ecoBlue 1 control.
e) Top (red): 1H NMR from HPLC faction 7; bottom (blue): 1H NMR from ecoBlue 1 control. (For
expanded NMR spectra see Appendix II).

The NMR spectra from Fractions 1-7 were compared to the ecoBlue 1 control spectrum
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to identify unique peaks (Figure 8c-e). As demonstrated by the natural product examples
presented in the introduction, many natural products have aromatic properties. Thus
particular attention was paid to comparing the 6.0-8.0 ppm regions of the control and
experimental spectra to target aromatic compounds. F4, F6, and F7 showed potentially
novel peaks in the aromatic region of their spectra when compared with the control
spectrum. F4 was ultimately selected for further analysis. To further analyze F4, 13C,
HMBC, HSQC, COSY and NOESY experiments were performed (Figure 9) in order to
propose a structure for the isolated compound. The proposed structure and related NMR
data are presented in Figure 10.

Figure 9. Fraction 4 NMR spectra. a) 1H NMR spectrum b) 13C NMR spectrum c) HMBC NMR
spectrum d) HSQC NMR spectrum
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1-(2-nitrosoethyl)-2-benzofuran
Position

13

1

Mult.

J (Hz)

1

63.7

3.86 (2H)

t

7.3

2

29.8

3.03 (2H)

td

7.3, 0.9

3

112.7

4

128.9

5

112.2

7.37 (1H)

dt

8.1, 1.0

6

119.5

7.04 (1H)

ddd

8.0, 7.0, 1.1

7

122.3

7.12 (1H)

ddd

8.0, 6.9, 1.1

8

119.2

7.58 (1H)

dt

7.9, 1.0

9

138.1

10

123.5

7.12 (1H)

s

C

H

Figure 10. H1 and C13 chemical shift assignments and proposed structure.
1

H NMR (500 MHz, Methanol-d4) δ 7.58 (dt, J = 7.9, 1.0 Hz, 1H), 7.37 (dt, J = 8.1, 1.0

Hz, 1H), 7.12 (ddd, J = 8.0, 6.9, 1.1 Hz, 2H), 7.12 (s, 1H), 7.04 (ddd, J = 8.0, 7.0, 1.1 Hz,
1H), 3.86 (t, J = 7.3 Hz, 2H), 3.03 (td, J = 7.3, 0.9 Hz, 2H).
C NMR (126 MHz, Methanol-d4) δ 138.13, 128.92, 123.51, 122.18, 119.47, 119.23,

13

112.73, 112.15, 63.68, 29.81.

Craig
1

13

H NMR showed five peaks in the aromatic region (7.04, 7.12, 7.12, 7.37, and 7.58 ppm)

with equal integration values. There was an overlap of peaks occurring at 7.12 ppm of a
singlet and a doublet of doublet of
doublets. Four of the peaks (7.04, ddd;
7.12, ddd; 7.37, dt; 7.58, dt) were
indicative of a 1,2 di-substituted benzene
ring, with the downfield proton peaks
located ortho relative to the two
substituents in positions 9 and 4 above,
and the upfield proton peaks meta relative
to the two substituents in positions 6
and 7 above. This was supported by
the splitting patterns and coupling
constants: the ddd splitting with two
coupling constants of 7.0 Hz and 8.0

Figure 11. Proton coupling resulting in a ddd
splitting pattern. The proton at position six shows
ortho coupling to two non-equivalent protons on
adjacent carbons (blue arrows). The same proton also
shows meta coupling to the proton at position 8 (purple
arrow). The same pattern is observed for the proton at
position 7.

Hz (located at positions 6 and 7) is likely due to ortho coupling, as protons at the 6 and 7
position on the benzene ring would each be located on adjacent carbons, with each
having two non-equivalent protons in the ortho positions (Figure 11). The carbon-proton
pairs were discerned using the HSQC data. HMBC was then used in conjunction with the
proton splitting patterns discussed above to determine the location of each proton-carbon
pair within the aromatic ring. COSY and NOESY spectra supported the relative position
of protons located on the isobenzofuran ring system, as well as on the ethyl-based
substituent. The final proposed assignments can be seen in Figure 10.

The dt peaks at 7.37 and 7.58 ppm were more difficult to rationalize. The coupling
constant associated with the doublet splitting pattern (close to 8.0 Hz for both dt protons)
indicates ortho coupling with each proton’s respective neighbor (at positions 5 and 6). It
seems likely that the triplet splitting pattern is the result of fine structure. The low
coupling constants of the triplets (< 1.0 Hz in most cases), would seem to suggest para
coupling across the ring. The combination of ortho, meta, and para coupling at the 3 and
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6 positions along the ring may suggest that in fact the dt is a ddd, with the fine structure
resulting from the para coupling overlapping to some extent.
The 1H spectrum shows a very clear triplet at 3.86 ppm and a triplet of doublets at 3.04
ppm, both integrating to two protons each. HSQC data showed that these two peaks
coupled with carbons at 63.68 and 29.81 ppm, respectively. HMBC confirmed that the
two methylenes were likely neighbors, as there was strong coupling observed between
both of the groups. This indicated the presence of an ethyl-based substituent group. The
protons located on the methylenes did not, however, couple into the benzene ring system
according to the HMBC data, making it less likely that this ethyl group was a substituent
located at position 4 and 9 on di-substituted benzene ring.

By comparing HMBC and HSQC results, four carbons were identified that were likely
quaternary carbons. These suspected quaternary carbons were 13C peaks located at 138.1,
128.9, 123.5, and 112.7 ppm. The downfield chemical shifts of these peaks indicated that
they were likely aromatic carbons. HMBC showed that the peaks at 138.1 and 128.9 ppm
both coupled strongly with the methines identified as part of the 1,2 disubstituted benzene
ring. It was determined that the peak at 138.13 ppm was located at the 4 position, and the
peak at 128.92 ppm at the 9 position using the HMBC data provided. The carbon peak at
138.1 ppm in turn coupled to the singlet peak at 7.12 ppm. The carbon peak at 128.9
coupled to the quaternary carbon located at 112.7 ppm. This quaternary carbon coupled
strongly into the ethyl group discussed above, indicating it was likely the position where
the ethyl substituent attached to the ring system (position 9). Of the two methylene
carbons on the ethyl substituent, the carbon at 29.8 ppm appeared to couple fairly
strongly into the ring system, indicating it was the carbon attached to the ring. The
second ethyl carbon at 63.7 ppm appears to be split solely by the two protons located on
the methylene at 29.8 ppm. The downfield shift to 63.7 ppm would appear to be
associated with a nitro-like group.

Ultimately a nitroso group was selected based upon the chemical shifts predicted by
ChemDraw 1H NMR prediction software. Another likely candidate for this position is a
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halogen species. Placing a bromine atom on the ethyl substituent yielded a similar
downfield shift as the nitroso group according to the ChemDraw prediction software. If
this is the case, mass spectrometry data should show two peaks of approximately equal
intensity with a difference of two m/z units between them, each corresponding to the
molecular ion but one with the 79Br isotope and the other containing the 81Br isotope. An
oxygen was selected to complete the five-membered ring, however this too cannot be
confirmed without a molecular weight provided by mass spectrometry data. A fused
benzene-furan with a 2-nitroso ethyl substituent seems a likely potential candidate for the
isolated molecule.

Figure 12. Predicted synthesis products based on antiSMASH analysis. Products of six sequenced
gene clusters are shown above. The predicted structures do not include tailoring reactions that would
occur to create the products’ final form. All reported products contained greater than 10 carbons.
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antiSMASH analysis15 of the SW202 genome done by our lab provided predicted
structures for the products of the NRPS and PKS gene clusters present in the SW202
microbe (Figure 12). All of these proposed structures had greater than 10 carbons. This
may indicate that the proposed 1-(2-nitrosoethyl)-benzofuran isolate is a partial product
of an NRPS and PKS cluster. In order to confirm this the fosmid insert from colony A
will have to be sequenced.

CONCLUSION
According to the NMR data collected, we were able to successfully isolate a chemical
entity not present in a control culture of ecoBlue 1 cells. The proposed identity of this
chemical entity is a 1-(2-nitrosoethyl)-benzofuran, however further analysis using mass
spectrometry will be required to determine the presence of any nitrogen and halogen
species. Further research will also be required to determine whether or not the isolate in
question is the product of an NRPS or PKS gene cluster. While our functional screen has
determined the presence of PPTase in the ecoSW202A sample, it is unclear if a full gene
cluster was isolated, and if it was, whether or not this is a direct product.

This compound, as well as the various collected fractions, will need to be screened for
bioactivity. If a promising isolate is characterized, we will apply for the NCI-60
screening program operated by the National Cancer Institute. This program screens
novel, primarily heterocyclic aromatic compounds, for activity against 60 different cancer
cell lines. In addition, the lab will explore chemical genomic screens on yeast strains to
determine the biological pathways involved in the mechanism of action for promising
isolates. Disk diffusion assays against Gram-negative and Gram-positive bacterial strains
will also be performed.

15

Medema, M. H.; Blin, K.; Cimermancic, P.; de Jager, V.; Zakrzewski, P.; Fischbach, M. A.; Weber, T.;
Breitling, R.; Takano, E. antiSMASH: Rapid identification, annotation and analysis of secondary
metabolite biosynthesis gene clusters. Nucleic Acids Research 2011; doi: 10.1093/nar/gkr466.
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The current data collected for ecoSW202A are promising. With luck, further work will be
able to determine if our isolate has any promising bioactive, and successfully link it to
one of the NRPS or PKS gene clusters that we have sequenced from the SW202 genome.
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APPENDIX I: COLUMN METHODS

Diaion ® HP-20 Column
The Diaion ® HP-20 column was used to fractionate 2 L cell cultures. For 2L cultures, a
30 mL column was packed. Cultures were centrifuged at 6,000 xg. The sample was then
decanted, and the supernatant collected. The cell pellet was stored at -20 °C for later use.

Supernatant
The column was prepared with successive washes of 100% acetone, water, and methanol
(three column volumes each). Once prepped, the supernatant was applied to the column
and the flow-through discarded. The bound molecules were eluted from the column in
50%, 75%, and 100% acetone solutions (three column volumes each). The fractions were
dried via rotary evaporation (when about 3 mL of solution was left in the round-bottom
flask, the solution was transferred to a 20 mL scintillation vial) and placed on the freezedrier overnight. The dried fractions were stored at -20 °C for later use.

Cell Pellet
Methanol (20 mL) was added to the cell pellet and vortexed. The extraction mixture was
allowed to sit overnight. The mixture was then centrifuged at 6000 xg, and the
supernatant was collected. The remaining cell pellet underwent a second extraction in
methanol overnight. The mixture was once again centrifuged as described above, and the
supernatants combined. The column was then prepared with successive washes of 100%
acetone, water, and methanol (three column volumes each). The methanol extract was
then applied to the column and the flow-through collected and diluted 1:1 with water.
The solution was then reapplied to the column. This process was repeated a two
additional times (additional dilutions may be necessary if the flow-through is not clear).
The final flow-through was discarded and the bound molecules eluted in three column
volumes of 50%, 75%, and 100% acetone solutions. The fractions were dried using the
method described in the above section. The dried fractions were stored at -20 °C.
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Diaion® HP20SS Backloading
Diaion® HP20SS columns were used to remove water from samples after HPLC
chromatography to remove water and thus reduce drying times. The procedure is as
follows.

Fractions were diluted until approximately 25% organic solvent by volume. A 3 mL
HP20SS column was packed and prepped using successive washes of 100% acetone,
water and methanol (three column volumes each). The fraction was then applied to the
column and the flow-through discarded. The bound molecules were then eluted in three
column volumes of 50%, 75%, and 100% acetone. The sample was then dried via rotary
evaporation and placed on the freeze drier overnight.

Diol Columns
Diol columns were used to fractionate samples after going through one round of HP-20
column chromatography, and before HPLC. Diol has a binding capacity of 6 mg/mL.

A Diol column was packed and prepped with three column volumes of the most nonpolar
solvent to be used. For the majority of the samples run dichloromethane (DCM), ethyl
acetate (EtAc), and methanol (MeOH) were the desired solvents. Mixtures of these
solvents were prepared prior to running the column. The fractions selected were mixed in
solutions of increasing polarity (i.e. in order: DCM, 3:1 DCM:EtAc, 1:1 DCM:EtAc, 1:3
DCM:EtAc, EtAc, 3:1 EtAc:MeOH etc.). The solution of interest was applied to the
prepped column, and the supernatant discarded. Starting with the most non-polar solvent
solution and progressing to the most polar, the bound molecules were eluted from the
column. The fractions were then dried via rotary evaporation and then placed on the
freeze drier overnight. The dried fractions were stored at -20 °C.

HPLC
A C-18 Semi-Prep column was used for all HPLC described in this paper. The column
was equilibrated incrementally, beginning with 100% methanol at 4 mL/min. The water
content of the solvent solution was increased by 10% every ten minutes until a 1:1
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methanol:water solution was reached. For the Agilent 1100 series the maximum injection
volume is 100 L, and the maximum solute mass is 10 g per run. The 224.0 mg sample
discussed in this paper was dissolved in 10 mL of methanol. Ultimately, 100 L
injections were used with a 1:1 methanol:water solvent solution at 4 mL/min with 20 min
runs. The UV-vis was set to detect at 254 nm.

APPENDIX II: NMR TECHNIQUES AND RESULTS

NMR Programs for Bruker 500

EXPERIMENT

PROGRAM

RUN DURATION

1H

PROTON_UR

10+ min

13C

CARBON_UR

overnight/weekend

HMBC

JD_HMBC

overnight

HSQC

JD_HSQCED

overnight

NOESY

COSY_UR

overnight

COSY

NOESY_UR

overnight

Table 2. NMR Experiments with associated University of Richmond Bruker Topspin programs
and typical run times.

Fraction 4

Fraction 6

Fraction 7

1

H NMR

13

C NMR

HMBC

HSQC

NOESY

COSY

